Home

Quick Product Lists

Login/Register

My Account

  View Cart

In Business 32 Years - Since 1980

THE CURRENT TIME at LC Labs is:  

Gamcitabine — see its active ingredient, namely Gemcitabine, Free Base, Cat. No. G-4199 and Gemcitabine, Hydrochloride Salt, Cat. No. G-4177.

GDC-0449 — see Vismodegib, Free Base, Cat. No. V-9040.

G-9252

GDC-0941, Free Base, >99%

G-4408

Gefitinib, Free Base, >99%

G-4500

Geldanamycin, >99%

Geldanomycin — see Geldanamycin, Cat. No. G-4500.

G-4199

Gemcitabine, Free Base, >99%

G-4177

Gemcitabine, Hydrochloride Salt, >99%

Gemcitera — see its active ingredient, namely Gemcitabine, Free Base, Cat. No. G-4199 and Gemcitabine, Hydrochloride Salt, Cat. No. G-4177.

Gemsar — see its active ingredient, namely Gemcitabine, Free Base, Cat. No. G-4199 and Gemcitabine, Hydrochloride Salt, Cat. No. G-4177.

Gemzar — see its active ingredient, namely Gemcitabine, Free Base, Cat. No. G-4199 and Gemcitabine, Hydrochloride Salt, Cat. No. G-4177.

G-6055

Genistein, >99%

G-5200

Genistin, >99%

GLD-36 — see 17-AAG, Cat. No. A-6880.

Glamox — see its active ingredient, namely Imatinib, Free Base, Cat. No. I-5577 and Imatinib, Methanesulfonate Salt, Cat. No. I-5508.

Gleevec — see its active ingredient, namely Imatinib, Free Base, Cat. No. I-5577 and Imatinib, Methanesulfonate Salt, Cat. No. I-5508.

Glivec — see its active ingredient, namely Imatinib, Free Base, Cat. No. I-5577 and Imatinib, Methanesulfonate Salt, Cat. No. I-5508.

G-1152

Glycitein, >99%

G-2822

Glycitin, >99%

Goe 5549 — see CI-994, Free Base, Cat. No. C-2606.

Gö 5549 — see CI-994, Free Base, Cat. No. C-2606.

G-6203

Gö 6976, >99%

GSK-3 Inhibitor XVI — see CHIR99021, Free Base, Cat. No. C-6556.

GSK 572016 — see Lapatinib, Free Base, Cat. No. L-4899.

G-5903

GW2580, Free Base, >99%

GW-572016 — see Lapatinib, Free Base, Cat. No. L-4899 and Lapatinib, Di-p-Toluenesulfonate Salt, Cat. No. L-4804.

GW 572016X — see Lapatinib, Free Base, Cat. No. L-4899.

GW-786034 — see Pazopanib, Free Base, Cat. No. P-6706.

H-5239

H-89, Dihydrochloride Salt, >99%

HA-1077 — see Fasudil, Monohydrochloride Salt, Cat. No. F-4660 and HA-1077, Dihydrochloride Salt.

H-2330

HA-1077, Dihydrochloride Salt, >99%

Halochondrine A — see Okadaic Acid, Free Acid, Cat. No. O-2220.

Halochondrine A, Ammonium Salt — see Okadaic Acid, Ammonium Salt, Cat. No. O-6410.

Halochondrine A, Potassium Salt — see Okadaic Acid, Potassium Salt, Cat. No. O-7519.

Halochondrine A, Sodium Salt — see Okadaic Acid, Sodium Salt, Cat. No. O-5857.

HhAntag691 — see Vismodegib, Free Base, Cat. No. V-9040.

Histone Deacetylase Inhibitor I — see Entinostat, Free Base, Cat. No. E-3866.

HKI-272 — see Neratinib, Free Base, Cat. No. N-6404.

Hycamptamine — see its active ingredient, namely Topotecan, Hydrochloride Salt, Cat. No. T-9622.

Hycamtin — see its active ingredient, namely Topotecan, Hydrochloride Salt, Cat. No. T-9622.

14-Hydroxydaunomycin — see Doxorubicin, Free Base, Cat. No. D-4099 and Doxorubicin, Hydrochloride Salt, Cat. No. D-4000.

14-Hydroxydaunorubicine — see Doxorubicin, Free Base, Cat. No. D-4099 and Doxorubicin, Hydrochloride Salt, Cat. No. D-4000.

I-5577

Imatinib, Free Base, >99%

Imatinib Mesylate — see Imatinib, Methanesulfonate Salt, Cat. No. I-5508.

I-5508

Imatinib, Methanesulfonate Salt, >99%

Immunomycin — see Ascomycin, Cat. No. A-1040.

INCB018424 — see Ruxolitinib, Free Base, Cat. No. R-6600 and Ruxolitinib, Phosphate Salt, Cat. No. R-6688.

INCB18424 — see Ruxolitinib, Free Base, Cat. No. R-6600 and Ruxolitinib, Phosphate Salt, Cat. No. R-6688.

IND-71677 — see Iniparib, Cat. No. I-5432.

I-1711

(-)-Indolactam V, >99%

I-8560

Ingenol, >99%

I-5900

Ingenol 3-Angelate, >99%

3-Ingenyl Angelate — see Ingenol 3-Angelate, Cat. No. I-5900.

Ingenyl 3-Angelate — see Ingenol 3-Angelate, Cat. No. I-5900.

I-5432

Iniparib, 99%

Intedanib — see Vargatef, Cat. No. V-9077.

4-Iodo-3-nitrobenzamide — see I-5432 Iniparib, Cat. No. I-5432.

I-6800

Ionomycin, Calcium Salt, >99%

I-5700

Ionomycin, Free Acid, >99%

Iressa — see its active ingredient, namely Gefitinib, Free Base, Cat. No. G-4408.

I-4122

Irinotecan, Hydrochloride Salt, Trihydrate, >99%

4',7-Isoflavandiol — see Equol, Cat. No. E-5880.

Jakafi — see its active ingredient, namely Ruxolitinib, Free Base, Cat. No. R-6600 and Ruxolitinib, Phosphate Salt, Cat. No. R-6688.

JNK Inhibitor II — see SP600125, Cat. No. S-7979.

K-2151

K252a, >99%

K-9609

K252c, >99%

K-252a — see K252a, Cat. No. K-2151.

K-252c — see K252c, Cat. No. K-9609.

KOS-953 — see 17-AAG, Cat. No. A-6880.

KRN-951 — see Tivozanib, Free Base, Cat. No. T-6466.

KRX-0401 — see Perifosine, Free Base, Cat. No. P-6522.

KT-5555 — see Lestaurtinib, Cat. No. L-6307.

K-9090

KU-0063794, Free Base, >99%

KU-59436 — see Olaparib, Cat. No. O-9201.

KU-63794 — see KU-0063794, Free Base, Cat. No. K-9090.

KW-2307 — see Vinorelbine, Ditartrate Salt, Cat. No. V-8766 and Vinorelbine, Free Base, Cat. No. V-8799.

KY 12420 — see Wortmannin, Cat. No. W-2990.